Lucid Diagnostics Inc. Quarterly Selling and Marketing Expense in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Lucid Diagnostics Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2021 to Q2 2024.
  • Lucid Diagnostics Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $4.21M, a 4.42% increase year-over-year.
  • Lucid Diagnostics Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $16.6M, a 2.65% decline year-over-year.
  • Lucid Diagnostics Inc. annual Selling and Marketing Expense for 2023 was $16.4M, a 1.67% increase from 2022.
  • Lucid Diagnostics Inc. annual Selling and Marketing Expense for 2022 was $16.1M, a 207% increase from 2021.
  • Lucid Diagnostics Inc. annual Selling and Marketing Expense for 2021 was $5.26M, a 303% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16.6M $4.21M +$178K +4.42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $16.5M $4.19M +$67K +1.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $16.4M $4.41M -$605K -12.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $17M $3.84M -$93K -2.37% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $17.1M $4.03M +$159K +4.11% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $16.9M $4.13M +$809K +24.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $16.1M $5.01M +$2.38M +90.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $13.8M $3.93M +$3.01M +328% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $10.7M $3.87M +$2.85M +279% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $7.89M $3.32M +$2.63M +382% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.26M $2.63M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $918K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.02M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $689K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.